期刊文献+

双能CT在诊断痛风心血管损害中的应用价值

Application value of dual-energy CT in diagnosis of gout cardiovascular damage
下载PDF
导出
摘要 痛风是由尿酸钠结晶沉积在关节或其他组织中引起的一种常见的疾病,其发病率和患病率呈逐年上升趋势,高尿酸血症是发展为痛风最重要的危险因素。近年来许多流行病学和实验研究均证实痛风与高血压、冠心病和心肌梗死等心血管疾病的发生和死亡密切相关。而双能CT作为一种新型的无创性影像学检查手段,可以特异性并定量显示尿酸盐结晶,近年来已成为诊断痛风的一个有效工具,有研究发现其在痛风心血管损害的诊断中也有着很好的临床价值。该综述分析痛风与心血管疾病之间复杂的相关性,以及双能CT在诊断痛风心血管损害中的优势和应用价值。 Gout is a common disease caused by the deposition of sodium urate crystals in joints or other tissues,and its incidence and prevalence are increasing year by year.Hyperuricemia is the most important risk factor for gout.In recent years,many epidemiological and empirical studies have confirmed that gout is closely related to the occurrence and death of cardiovascular diseases such as hypertension,coronary heart disease and myocardial infarction.Dual-energy CT,as a new non-invasive imaging modality,can specifically and quantitatively display urate crystals,and has become an effective tool for the diagnosis of gout in recent years,and some studies have found its clinical value in the diagnosis of cardiovascular damage in gout.This review analyzes the complex correlation between gout and cardiovascular diseases,and the advantages and application value of dual-energy CT in the diagnosis of cardiovascular damage in gout.
作者 隋昂 易大勇 周迪军 SUI Ang;YI Dayong;ZHOU Dijun(Department of Endocrinology,Yueyang People's Hospital,Hunan Normal University,Yueyang,Hunan 414000,China;Department of Radiology,Yueyang People's Hospital,Hunan Normal University,Yueyang,Hunan 414000,China)
出处 《中国动脉硬化杂志》 CAS 2023年第6期546-552,共7页 Chinese Journal of Arteriosclerosis
基金 湖南省卫生健康委员会科研项目(202109010020)。
关键词 高尿酸血症 尿酸钠晶体 痛风 双能CT 心血管疾病 hyperuricemia monosodium urate crystal gout dual-energy CT cardiovascular disease
  • 相关文献

参考文献4

二级参考文献55

  • 1Rudan D, Polasek O, Kolci I, et al. Uric acid: the past decade [J]. Croat MedJ, 2010, 51 (1): 1-6.
  • 2Feig DI, Johnson RJ. Hyperuricemia in childhood primary hyperten- sion [J]. Hypertension, 2003, 42 (3): 247-252.
  • 3Villegas R, Xiang YB, Cai Q, et al. Prevalence and determinants of hyperuricemia in middle-aged, urban chinese men[ J ]. Metab Syndr Relat Disord, 2010, 8 (3): 263-270.
  • 4Krishnan E, Pandya BJ, Chung L, et al. Hyperuricemia and the risk for subclinical coronary atherosclerosis-data from a prospective observational cohort study [J]. Arthritis Res Ther, 2011, 13 (2) : R66.
  • 5Oikonen M, Wendelin-Saarenhovi M, Lyytik inen LP, et al. Asso- ciations between serum uric acid and markers of subclinical athero- sclerosisin young adults. The cardiovascular risk in Young Finns study[ J ]. Atherosclerosis, 2012, 223 (2) : 497-503.
  • 6Strazzullo P, Puig JG. Uric acid and oxidative stress:relative impact on cardiovascular risk [ J] ? Nutr Metab Cardiovasc Dis, 2007, 17 (6) : 409-414.
  • 7Sanchez-Lozada LG, Soto V. Role of oxidative stress in the renal abnormalities induced by experimental hyperuricemia [ J ]. Am J Physiol Renal Physiol, 2008, 295:1 134-141.
  • 8Gur M, Sahin DY, Elbasan Z, et al. Uric acid and high sensitive C-reactive protein are associated with subclinical thoracic aortic atheroselerosis[J]. J Cardiol, 2013, 61 (2) : 144-148.
  • 9Ndrepepa G, Braun S, King L, et al. Uric acid and prognosis in angiography-proven coronary artery disease[ J]. Eur J Clin Invest, 2013, 43 (3) : 256-266.
  • 10Kuo CF, See LC, Yu KH, et al. Significance of serum uric acid levels on the risk of all-cause and cardiovascular mortality [ J ]. Rheumatology, 2013, 52: 127-134.

共引文献62

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部